S Squared Technology, LLC Axogen, Inc. Transaction History

S Squared Technology, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $653,601 - $989,343	-44,706 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $764,025 - $1.71 Million	44,706 New	44,706 $913,000
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $3.49 Million - $5.07 Million	-96,501 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$24.4 - $40.25 $524,624 - $865,415	21,501 Added 28.67%	96,501 $3.52 Million
Q4 2017 Feb 13, 2018	BUY	$18.5 - $28.6 $514,041 - $794,679	27,786 Added 58.85%	75,000 $2.12 Million
Q3 2017 Nov 13, 2017	BUY	$14.65 - $19.35 $691,685 - $913,590	47,214	47,214 $914,000

132

35.8M

79.1K

500

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $611M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of S Squared Technology, LLC, based on Form 13F filings with the SEC.

Stay updated on S Squared Technology, LLC with notifications on news.